The history of Viagra, and its developer copyright, presents a challenging case study for investors. Initially a blockbuster drug, producing billions in income, its patent expiration created a deluge of lower-priced alternatives , significantly eroding its dominance. While certain pharmaceutical companies may seek to capitalize on similar condition